FDA Clears Encora X1 Wrist-Worn Device for Essential Tremor
The Encora X1 is a noninvasive, wrist-worn neurostimulation device designed to reduce hand tremors and improve daily function in adults with essential tremor.
The Encora X1 is a noninvasive, wrist-worn neurostimulation device designed to reduce hand tremors and improve daily function in adults with essential tremor.
A new study projects that global ALS prevalence will rise by about 25% by 2040—driven largely by an aging population and improved survival.
Innovations in rehabilitation techniques—from telehealth to advanced neurotechnology—are enhancing recovery outcomes for stroke survivors.
LimFlow’s FDA approval follows study results which found that the therapy enabled most patients treated to keep their leg and experience wound healing.
As more adults focus on improving their health in 2025, this is a good time to stress the importance of patients maintaining fine motor skills through targeted exercises and recreational activities to preserve independence and quality of life.
Scientists at UT Southwestern have identified the protein GADD45G as a master regulator of reactive gliosis, a damaging process in neurodegenerative diseases like Parkinson's and Alzheimer’s, offering a potential new therapeutic target.
A four-year distribution agreement for the Provizio SEM Scanner, used to prevent pressure injuries, has not been extended.
The research team for the new study conducted the largest genome-wide association meta-analysis ever performed on osteoarthritis.
High-frequency spinal cord stimulation effectively reduces muscle spasticity in patients with incomplete spinal cord injuries, enabling better rehabilitation outcomes.